antisense oligonucleotides (Ionis/Biogen)

N/A

Report date: 2025/03/14 16:32:26
NME

Base Information

Drug Nameantisense oligonucleotides (Ionis/Biogen)
Drug Alias Nameantisense oligonucleotides targeting Keap1 (Biogen and Ionis Pharmaceuticals)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 stimulantsKelch-like ECH-associated protein 1 modulators
TargetsNuclear factor erythroid 2-related factor 2Kelch-like ECH-associated protein 1
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesIonis Pharmaceuticals IncBiogen Inc
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A